19-11120162-T-G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP1_StrongPM5PM2PP4
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1916T>G (p.Val639Gly) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PP1_Strong, PM2, PM5 and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025.The supporting evidence is as follows:PM2: PopMax MAF = 0.00002196 (0.002196%) in South Asian exomes+genomes (gnomAD v4.1.0).PM5: 1 other missense variant in the same codon is classified as Pathogenic by these guidelines:- NM_000527.5(LDLR):c.1916T>A (p.Val639Asp) (ClinVar ID 200922). PP4: Variant meets PM2 and is identified in only 1 proband with MEDPED criteria for FH from Pakistan (PMID 22311046 – Ahmed et al., 2012), after alternative causes of high cholesterol were excluded.PP1_Strong: Variant segregates with FH phenotype in 9 informative meiosis from 1 family from Pakistan (PMID 22311046 – Ahmed et al., 2012): 6 affected family members have the variant and 3 unaffected family members do not have the variant. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10585680/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | c.1916T>G | p.Val639Gly | missense_variant | Exon 13 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LDLR | ENST00000558518.6 | c.1916T>G | p.Val639Gly | missense_variant | Exon 13 of 18 | 1 | NM_000527.5 | ENSP00000454071.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461704Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727172 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:2
The NM_000527.5(LDLR):c.1916T>G (p.Val639Gly) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PP1_Strong, PM2, PM5 and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on January 31, 2025. The supporting evidence is as follows: PM2: PopMax MAF = 0.00002196 (0.002196%) in South Asian exomes+genomes (gnomAD v4.1.0). PM5: 1 other missense variant in the same codon is classified as Pathogenic by these guidelines: - NM_000527.5(LDLR):c.1916T>A (p.Val639Asp) (ClinVar ID 200922). PP4: Variant meets PM2 and is identified in only 1 proband with MEDPED criteria for FH from Pakistan (PMID 22311046 – Ahmed et al., 2012), after alternative causes of high cholesterol were excluded. PP1_Strong: Variant segregates with FH phenotype in 9 informative meiosis from 1 family from Pakistan (PMID 22311046 – Ahmed et al., 2012): 6 affected family members have the variant and 3 unaffected family members do not have the variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at